Health

  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Downloads
    • Dvd
    • Games
    • Software
      • Office
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Uncategorized

Thursday, January 23, 2025

Ozempic’s health benefits keep growing, but are the risks worth it?

 January 23, 2025     Health, Health News Today on Fox News     No comments   

One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show — and now a major new study has revealed a long list of benefits and some little-known risks.

Glucagon-like peptide-1 receptor (GLP-1) agonists — which contain either semaglutide or liraglutide — are prescribed to treat type 2 diabetes and obesity, but previous studies have linked the drugs to other, unexpected benefits.

Researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs (VA) St. Louis Health Care System studied the health outcomes of more than two million veterans with diabetes who took Ozempic or another type of GLP-1 drug between Oct. 1, 2017 and Dec. 31, 2023, according to a university press release.

OZEMPIC 'MICRODOSING' IS THE NEW WEIGHT-LOSS TREND

They then compared those outcomes to veterans who took non-GLP-1 diabetes medications.

The study, published in the journal Nature on Jan. 20, identified "widespread associations" between Ozempic and some significant health benefits.

Those benefits included reduced risks of neurocognitive disorders like Alzheimer’s and dementia, seizures, and addiction to harmful substances such as alcohol, cannabis, stimulants and opioids.

Other positive health effects included lower risks of suicidal ideation, self-harm, bulimia and psychotic disorders such as schizophrenia.

OZEMPIC COULD HELP REDUCE ALZHEIMER’S RISK FOR SOME, STUDY SUGGESTS: ‘SHIFTING THE PARADIGM’

"GLP-1s have many benefits for at least 42 conditions beyond weight loss – from addiction disorders to memory/cognition problems, blood clots, and infections," lead study author Ziyad Al-Aly, clinical epidemiologist at Washington University in St. Louis, told Fox News Digital.

Ozempic and other GLP-1 drugs act on receptors in the brain that are involved in impulse control, reward and addiction, Al-Aly noted, which could explain why they are effective in reducing cravings for food and addictive substances.

"These drugs also reduce inflammation in the brain and result in weight loss; both of these factors may improve brain health and explain the reduced risk of conditions like Alzheimer’s disease and dementia," he added.

They also found, however, that GLP-1 drugs were linked to several adverse side effects.

The risk of gastrointestinal problems — including nausea, vomiting, diarrhea and a rarer paralysis of the stomach — were widely known before this new study, the researcher noted.

The new finding, however, was that these drugs can negatively affect the pancreas and kidneys. They were also linked to a higher chance of developing arthritis.

DIABETES AND WEIGHT LOSS DRUGS SHOWN TO REDUCE ALCOHOL-RELATED HOSPITALIZATIONS, STUDY FINDS

"While these adverse effects are uncommon, they can be very serious; physicians must be vigilant for signs of pancreatitis (inflammation of the pancreas) and monitor kidney function among people taking GLP-1RA medications," Al-Aly stated in the press release. 

"Kidney problems can occur without symptoms until the condition is at an advanced stage with limited treatment options."

The study, which was funded by the U.S. Department of Veterans Affairs, did have some limitations, the researchers acknowledged. 

"This is a discovery approach involving more than two million people and is not a randomized trial," Al-Aly told Fox News Digital.

Seth Kipnis, MD, medical director of bariatric and robotic surgery at Hackensack Meridian Jersey Shore University Medical Center, was not involved in the study but said it confirms what he has seen in his own clinical practice.

"People with real weight loss are happier overall — they feel empowered that they can finally control their weight," he said in a statement sent to Fox News Digital.

Decreased obesity has long been linked with less inflammation in every body system, Kipnis pointed out. 

"GI problems and renal problems will always be seen if people are not eating correctly and maintaining hydration," he said. "If you take these medications without nutritional education, they can be harmful."

Based on the findings, the researchers noted, people should be aware that these drugs have not only a "broad beneficial profile," but also important risks. 

"People should use the information to discuss with their provider whether GLP-1 is the right medication for them," Al-Aly recommended. 

"A person who is trying to lose weight and quit smoking or drinking may find GLP-1s especially useful – helping hit two birds with one stone — but a person with a lot of GI (gastrointestinal) issues may find these meds intolerable," he went on.

"Each person’s health profile is different. Pros and cons should be discussed with the provider."

CHEAP OZEMPIC KNOCK-OFFS HAVE RISEN IN POPULARITY

Given their effectiveness at causing weight loss and improving health, GLP-1 drugs will likely become more common and increase in use, Hackensack’s Kipnis predicted.

"We have been prescribing many long-term drugs for hypertension, heart disease, high cholesterol, diabetes, arthritis, reflux and many other diseases without hesitation," he said.

"This new class of drug, as it lowers obesity, has the potential to lower the use of every other drug that is used to treat obesity-related conditions."

Not every doctor should prescribe these medications, however, according to Kipnis.

"Doctors with weight management programs and nutrition education programs would likely have better outcomes and fewer side effects," the doctor said.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Novo Nordisk, the maker of Ozempic (approved for type 2 diabetes treatment and reduced risk of cardiovascular events) and Wegovy (approved for weight management and reduced risk of cardiovascular events), provided the following statement to Fox News Digital.

 "Semaglutide has helped millions of people fight chronic diseases such as type 2 diabetes, cardiovascular disease and obesity. As we look to help even more people with chronic diseases, we are exploring the potential of semaglutide in several other disease states."

"Patient safety is of utmost importance to Novo Nordisk. The known risks and benefits of semaglutide medicines are described in their FDA-approved product labeling and we work closely with authorities and regulatory bodies worldwide to continuously monitor the safety profile of our products."

For more Health articles, visit www.foxnews.com/health

The company added that the "totality of data" from previous studies "provides reassurance of the safety profile of semaglutide."



from Health News Today on Fox News https://ift.tt/UMo7pjE
  • Share This:  
  •  Facebook
  •  Twitter
  •  Google+
  •  Stumble
  •  Digg
Email ThisBlogThis!Share to XShare to Facebook

Related Posts:

  • New Mexico reports Texas measles outbreak has now crossed it's borderThe Texas Department of State Health and Services (DSHS) has been tracking an ever-growing measles outbreak that has nearly doubled in the last two we… Read More
  • Couple breaks record for longest living marriageTwo centenarians broke the Guinness World Record for longest marriage of a living couple, as reported by Jam Press and confirmed by LongeviQuest, a da… Read More
  • Experimental vaccine for common cancer shows potential in clinical trialA vaccine for pancreatic cancer could serve as a promising new therapy. At Memorial Sloan Kettering Cancer Center (MSK) in New York, an experimental a… Read More
  • Children with autism may see speech improvements with off-label prescription drugAn off-label prescription drug has been shown to help some non-verbal children with autism discover the ability to speak. The drug, leucovorin, is a p… Read More
  • Common cancer treatment can have this painful side effectDuring active cancer treatment, patients face many smaller battles on the path to remission. One of those lesser-known struggles is a condition known … Read More
Newer Post Older Post Home

0 comments:

Post a Comment

Popular Posts

  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD
  • As eating disorders increase among college students, here's how parents can help: ‘Early intervention is key’
    While most of us have heard about the "Freshman 15" — the stereotypical first-year weight gain among college students — a growing ...

Recent Posts

Categories

  • Health News Today on Fox News
  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Unordered List

Pages

  • Home

Text Widget

Blog Archive

  • June 2025 (18)
  • May 2025 (88)
  • April 2025 (84)
  • March 2025 (88)
  • February 2025 (70)
  • January 2025 (72)
  • December 2024 (81)
  • November 2024 (70)
  • October 2024 (82)
  • September 2024 (75)
  • August 2024 (82)
  • July 2024 (79)
  • June 2024 (74)
  • May 2024 (73)
  • April 2024 (78)
  • March 2024 (75)
  • February 2024 (78)
  • January 2024 (78)
  • December 2023 (60)
  • November 2023 (80)
  • October 2023 (74)
  • September 2023 (75)
  • August 2023 (85)
  • July 2023 (67)
  • June 2023 (58)
  • May 2023 (100)
  • April 2023 (105)
  • March 2023 (118)
  • February 2023 (84)
  • January 2023 (87)
  • December 2022 (69)
  • November 2022 (64)
  • October 2022 (78)
  • September 2022 (74)
  • August 2022 (110)
  • July 2022 (109)
  • June 2022 (127)
  • May 2022 (95)
  • April 2022 (109)
  • March 2022 (140)
  • February 2022 (138)
  • January 2022 (170)
  • December 2021 (182)
  • November 2021 (213)
  • October 2021 (506)
  • September 2021 (539)
  • August 2021 (564)
  • July 2021 (590)
  • June 2021 (556)
  • May 2021 (544)
  • April 2021 (310)
  • March 2021 (331)
  • February 2021 (301)
  • January 2021 (326)
  • December 2020 (521)
  • November 2020 (403)
  • October 2020 (537)
  • September 2020 (554)
  • August 2020 (431)
  • July 2020 (647)
  • June 2020 (610)
  • May 2020 (659)
  • April 2020 (681)
  • March 2020 (729)
  • February 2020 (564)
  • January 2020 (483)
  • December 2019 (396)
  • November 2019 (416)
  • October 2019 (526)
  • September 2019 (486)
  • August 2019 (441)
  • July 2019 (394)
  • June 2019 (381)
  • May 2019 (510)
  • April 2019 (471)
  • March 2019 (560)
  • February 2019 (403)
  • January 2019 (530)
  • December 2018 (382)
  • November 2018 (378)
  • October 2018 (510)
  • September 2018 (297)
Powered by Blogger.

Report Abuse

Formulir Kontak



Search This Blog

Find Us On Facebook

Labels

  • Health News Today on Fox News
  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Flickr Images

Most Popular

  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD
  • As eating disorders increase among college students, here's how parents can help: ‘Early intervention is key’
    While most of us have heard about the "Freshman 15" — the stereotypical first-year weight gain among college students — a growing ...
  • Pioneer of America's global HIV/AIDS program recalls hope after years of despair
    Through his office window at what was then one of Africa's few modern clinics dealing with HIV and AIDS , the man who now oversees the U...
  • Free COVID tests will again be available from US government starting next week
    The U.S. government is reactivating the program that mails free COVID-19 tests to Americans' homes upon request. Effective Sept. 25, h...
  • New COVID vaccine push is ‘anti-human,’ says Florida surgeon general: ‘Major safety concern’
    The new COVID-19 vaccine is now available at participating pharmacies and health care providers, and the Centers for Disease Control (CDC) ...
  • AI tech aims to help patients catch disease early even reverse their biological age
    In humanity's quest to live longer, healthier lives, technology — particularly artificial intelligence — is playing an ever-bigger role...
  • US scores D+ for preterm birth rates, says new report: ‘Falling further behind’
    The rate of preterm births remains alarmingly high in the U.S., according to the latest March of Dimes Report Card. The figure was around ...
  • FOX NEWS: Vermont fertility doctor accused of using his own sperm to inseminate woman 41 years ago: lawsuit
    Vermont fertility doctor accused of using his own sperm to inseminate woman 41 years ago: lawsuit A child conceived in 1977 through art...
  • Carbon monoxide deaths are climbing, putting families in peril: ‘My son is lucky to be alive’
    Often dubbed "the silent killer," carbon monoxide is colorless and odorless — it’s been shown to cause severe injury or death in h...

Sample Text

Copyright © 2025 Health | Powered by Blogger
Design by Hardeep Asrani | Blogger Theme by NewBloggerThemes.com | Distributed By Gooyaabi Templates